Page last updated: 2024-08-24

gemcitabine and apigenin

gemcitabine has been researched along with apigenin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, YT; Lee, KY; Lee, SH; Park, JK; Ryu, JK; Woo, SM; Yoo, JW; Yoon, YB1
Bentrem, DJ; Ding, XZ; McGill, JJ; Melstrom, LG; Milam, BM; Salabat, MR; Strouch, MJ; Ujiki, MB1
Gonzalez de Mejia, E; Johnson, JL1

Other Studies

3 other study(ies) available for gemcitabine and apigenin

ArticleYear
Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer.
    Cancer letters, 2008, Jan-18, Volume: 259, Issue:1

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apigenin; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Gemcitabine; Humans; Mice; NF-kappa B; Pancreatic Neoplasms; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays

2008
The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells.
    Pancreas, 2009, Volume: 38, Issue:4

    Topics: Antimetabolites, Antineoplastic; Apigenin; Apoptosis; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Flow Cytometry; G2 Phase; Gemcitabine; Humans; Mitosis; Pancreatic Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; S Phase

2009
Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2013, Volume: 60

    Topics: Antineoplastic Agents; Apigenin; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Synergism; Fluorouracil; Gemcitabine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Luteolin; Pancreatic Neoplasms; Signal Transduction; Transcription Factor RelA

2013